Evidence map›Paper›PMID 25801433›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

CD13 restricts TLR4 endocytic signal transduction in inflammation.

Mallika Ghosh, Jaganathan Subramani, M Mamunur Rahman, Linda H Shapiro

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Coronavirus Receptors as Immune Modulators.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Review
  14. Review
  15. Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoEEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  16. Review
  17. Anticoagulant and signaling functions of antithrombin.Journal of thrombosis and haemostasis : JTH · 2020
    Review
  18. Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin.Journal of thrombosis and haemostasis : JTH · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mallika GhoshCenter for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030 mghosh@uchc.edu lshapiro@uchc.edu.
Jaganathan SubramaniCenter for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030.
M Mamunur RahmanCenter for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030.
Linda H ShapiroCenter for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030 mghosh@uchc.edu lshapiro@uchc.edu.
UConn Health · US

Funding

Vascular Pathophysiology and History Core (VPHC)P01HL070694 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COWAN, ANN E. · 2002 to 2013
$17.5M
NHLBI NIH HHS HL-70694NHLBI NIH HHS P01 HL070694
6 · The paper itself

Abstract

Dysregulation of the innate immune response underlies numerous pathological conditions. The TLR4 is the prototypical sensor of infection or injury that orchestrates the innate response via sequential activation of both cell surface and endocytic signaling pathways that trigger distinct downstream consequences. CD14 binds and delivers LPS to TLR4 and has been identified as a positive regulator of TLR4 signal transduction. It is logical that negative regulators of this process also exist to maintain the critical balance required for fighting infection, healing damaged tissue, and resolving inflammation. We showed that CD13 negatively modulates receptor-mediated Ag uptake in dendritic cells to control T cell activation in adaptive immunity. In this study, we report that myeloid CD13 governs internalization of TLR4 and subsequent innate signaling cascades, activating IRF-3 independently of CD14. CD13 is cointernalized with TLR4, CD14, and dynamin into Rab5(+) early endosomes upon LPS treatment. Importantly, in response to TLR4 ligands HMGB1 and LPS, p-IRF-3 activation and transcription of its target genes are enhanced in CD13(KO) dendritic cells, whereas TLR4 surface signaling remains unaffected, resulting in a skewed inflammatory response. This finding is physiologically relevant as ischemic injury in vivo provoked identical TLR4 responses. Finally, CD13(KO) mice showed significantly enhanced IFNβ-mediated signal transduction via JAK-STAT, escalating inducible NO synthase transcription levels and promoting accumulation of oxidative stress mediators and tissue injury. Mechanistically, inflammatory activation of macrophages upregulates CD13 expression and CD13 and TLR4 coimmunoprecipitate. Therefore, CD13 negatively regulates TLR4 signaling, thereby balancing the innate response by maintaining the inflammatory equilibrium critical to innate immune regulation.

Indexed as

EndocytosisSignal TransductionAnimalsCD13 AntigensCell MembraneDendritic CellsEndosomesGene ExpressionInflammationInterferon Regulatory Factor-3IschemiaLipopolysaccharidesMacrophagesMiceMyeloid Differentiation Factor 88NitritesCD13 AntigensInterferon Regulatory Factor-3LipopolysaccharidesMyeloid Differentiation Factor 88NitritesToll-Like Receptor 4

Identifiers

PMID25801433
PMCPMC4402264
OpenAlexW1670964306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.